• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年 9 月至 11 月,与同期韩国同等年龄的普通人群相比,在韩国陆军训练中心招募的 9954 名新兵中 SARS-CoV-2 抗体的流行率比较。

Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020.

机构信息

Department of Preventive Medicine, Injae University School of Medicine, Busan, South Korea.

Department of Infectious Disease Research, Armed Forces Medical Research Institute, Daejeon, South Korea.

出版信息

Med Sci Monit. 2022 May 4;28:e934926. doi: 10.12659/MSM.934926.

DOI:10.12659/MSM.934926
PMID:35505583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9083215/
Abstract

BACKGROUND Understanding the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be a useful tool when studying spread of the disease. This study aimed to compare the prevalence of antibodies to SARS-CoV-2 in 9954 recruits in the Korean Army Training Center with the general Korean population age <30 years between September and November, 2020. MATERIAL AND METHODS At the Korean Army Training Center, samples were taken from 9954 men from September to November, 2020. Participants were randomly enlisted healthy adult men. The data were compared with 4,205,265 samples from the Korean general population. Men age <30 years were used, as this is similar to the age range of the military recruits. RESULTS Among military recruits, 31 subjects (0.31%) were positive for the antibody, while the Korean male population had 3757 (0.09%) positive individuals. Among these 31 men, 13 were previously diagnosed by PCR, while 18 (58.06%) had no history related to the disease. Positive military recruits were mostly from 2 regional clusters. The first cluster was Daegu and Gyeongbuk areas (1.97% and 0.80%, respectively), which had an outbreak in March, 2020. The second cluster was Gyeonggi and Seoul, or capital areas (0.23% and 0.20%, respectively), which currently has high PCR positivity. Overall, seroprevalence was 3.49 times higher in study subjects. CONCLUSIONS The high seroprevalence of antibodies to SARS-CoV-2 between September and November 2020 in a densely populated military academy in Korea may have been an indicator for the resulting outbreak of COVID-19 in winter 2020-21, which highlights the importance of asymptomatic spread from the young and healthy to the general population.

摘要

背景

了解严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的血清流行率在研究疾病传播时是一种有用的工具。本研究旨在比较 2020 年 9 月至 11 月在韩国陆军训练中心的 9954 名新兵与年龄<30 岁的韩国一般人群中 SARS-CoV-2 抗体的流行率。

材料与方法

在韩国陆军训练中心,于 2020 年 9 月至 11 月期间从 9954 名男性中采集样本。参与者为随机招募的健康成年男性。将数据与韩国一般人群的 4205265 个样本进行比较。使用年龄<30 岁的男性,因为这与新兵的年龄范围相似。

结果

在新兵中,有 31 例(0.31%)抗体阳性,而韩国男性人口中有 3757 例(0.09%)阳性个体。在这 31 名男性中,13 人经 PCR 诊断,而 18 人(58.06%)无相关疾病史。阳性新兵主要来自 2 个区域集群。第一个集群是大邱和庆尚北道地区(分别为 1.97%和 0.80%),2020 年 3 月爆发疫情。第二个集群是京畿道和首尔或首都地区(分别为 0.23%和 0.20%),目前 PCR 阳性率较高。总体而言,研究对象的血清流行率高 3.49 倍。

结论

2020 年 9 月至 11 月期间,韩国人口密集的军事学院 SARS-CoV-2 抗体高流行率可能是 2020-21 年冬季 COVID-19 爆发的指标,这凸显了无症状传播从年轻人和健康人群到一般人群的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1c/9083215/544f11d830bc/medscimonit-28-e934926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1c/9083215/544f11d830bc/medscimonit-28-e934926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1c/9083215/544f11d830bc/medscimonit-28-e934926-g001.jpg

相似文献

1
Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020.2020 年 9 月至 11 月,与同期韩国同等年龄的普通人群相比,在韩国陆军训练中心招募的 9954 名新兵中 SARS-CoV-2 抗体的流行率比较。
Med Sci Monit. 2022 May 4;28:e934926. doi: 10.12659/MSM.934926.
2
Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea.韩国首尔大都市地区第三波 COVID-19 期间 SARS-CoV-2 抗体的血清流行率。
Epidemiol Health. 2022;44:e2022085. doi: 10.4178/epih.e2022085. Epub 2022 Sep 30.
3
Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.韩国大邱6家主要医院2935名医护人员中SARS-CoV-2抗体的流行情况
J Korean Med Sci. 2021 Nov 8;36(43):e294. doi: 10.3346/jkms.2021.36.e294.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率:第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
6
Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.韩国无症状人群中抗SARS-CoV-2抗体的全国血清流行率:一项横断面研究。
BMJ Open. 2021 Apr 24;11(4):e049837. doi: 10.1136/bmjopen-2021-049837.
7
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.香港 3 波新冠疫情期间不明 SARS-CoV-2 感染的血清流行率。
JAMA Netw Open. 2021 Nov 1;4(11):e2132923. doi: 10.1001/jamanetworkopen.2021.32923.
8
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
9
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
10
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.苏格兰对 COVID-19 的强化监测:在疫情第一波期间对 SARS-CoV-2 进行基于人群的血清流行率监测。
Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24.

本文引用的文献

1
One-pot pre-coated interface proximity extension assay for ultrasensitive co-detection of anti-SARS-CoV-2 antibodies and viral RNA.一种用于超灵敏共检测抗 SARS-CoV-2 抗体和病毒 RNA 的一锅预涂界面接近延伸检测方法。
Biosens Bioelectron. 2021 Dec 1;193:113535. doi: 10.1016/j.bios.2021.113535. Epub 2021 Aug 4.
2
A HiPAD Integrated with rGO/MWCNTs Nano-Circuit Heater for Visual Point-of-Care Testing of SARS-CoV-2.一种集成有rGO/MWCNTs纳米电路加热器的HiPAD,用于SARS-CoV-2的可视化即时检测。
Adv Funct Mater. 2021 Jun 23;31(26):2100801. doi: 10.1002/adfm.202100801. Epub 2021 Apr 20.
3
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
利用日本神户市门诊留存血清估计新型冠状病毒病(COVID-19)血清阳性率:一项横断面研究。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100747. doi: 10.1016/j.cegh.2021.100747. Epub 2021 Apr 19.
4
Pre-coated interface proximity extension reaction assay enables trace protein detection with single-digit accuracy.预包被界面邻近延伸反应检测法能够以个位数精度实现痕量蛋白质检测。
Biosens Bioelectron. 2021 Jul 1;183:113211. doi: 10.1016/j.bios.2021.113211. Epub 2021 Apr 6.
5
Prolonged viral shedding and antibody persistence in patients with COVID-19.COVID-19 患者的病毒持续排出和抗体持续存在。
Microbes Infect. 2021 May-Jun;23(4-5):104810. doi: 10.1016/j.micinf.2021.104810. Epub 2021 Mar 17.
6
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
7
Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention.韩国 COVID-19 疫情第二波和第三波的比较:早期公共卫生干预的重要性。
Int J Infect Dis. 2021 Mar;104:742-745. doi: 10.1016/j.ijid.2021.02.004. Epub 2021 Feb 5.
8
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.新型冠状病毒肺炎患者和健康志愿者发病后 6 个月内抗 SARS-CoV-2 抗体的血清阳性率。
Eur J Immunol. 2020 Dec;50(12):2025-2040. doi: 10.1002/eji.202048970. Epub 2020 Nov 10.
9
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.COVID-19 患者血清和唾液中针对 SARS-CoV-2 刺突抗原的抗体反应持续存在。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe5511.
10
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.美国大型全国范围内透析患者样本中 SARS-CoV-2 抗体的流行情况:一项横断面研究。
Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25.